How to buy cannabis stock

On this page you will find a list of companies that in our opinion have long term potential. Companies that have technology and business models that we feel are unique and contain potential for the long term success within the Marijuana space. We are well aware that NO company especially in this sector is without its share of scrutiny.

HOWEVER, we DO NOT have all the answers and if ANY of YOU discover information, and or want to express your opinions or suggest a company to add and or take away we welcome your input. Please email us at info marijuanastocks. However we do reserve the right to publish a company that has advertised and or plans to advertise on this website and we will responsibly disclaim such compensation clearly for all to see.

Their Marinol drug is FDA-approved for the treatment of nausea in patients undergoing chemotherapy and is also prescribed to AIDS patients suffering from loss of appetite. The drug is made of a synthetic form of THC and is delivered as an oral capsule.

Although the DEA still classifies marijuana as a Schedule I drug, Marinol is listed as a Schedule III drug, meaning the FDA recognizes the clinical benefits and abuse potentials are believed to be lower. The company also offers Humira, a biologic therapy administered as a subcutaneous injection to treat autoimmune diseases; Imbruvica an oral therapy for the treatment of chronic lymphocytic leukemia; and Viekira Pak, an interferon-free therapy for adults with genotype 1 chronic hepatitis.

It also provides Kaletra, an anti-HIV-1 medicine used with other anti-HIV-1 medications as a treatment that maintains viral suppression in HIV-1 patients; Norvir, a protease inhibitor indicated in combination with other antiretroviral agents to treat HIV-1; and Synagis to prevent respiratory syncytial virus infection in high risk infants. In addition, the company offers AndroGel, a testosterone replacement therapy for males diagnosed with symptomatic low testosterone; Creon, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid to treat hypothyroidism; and Lupron, a product for the palliative treatment of prostate cancer, and endometriosis and central precocious puberty, as well as for the treatment of patients with anemia.

The company sells its products to wholesalers, distributors, government agencies, health care facilities, specialty pharmacies, and independent retailers from its distribution centers and public warehouses. The company is based in Vancouver, Canada. Using water from the Canadian Rocky Mountains, Aurora cannabis plants are brought to harvest in their 55, sq ft.

Their state-of-the-art facility is designed to produce the cleanest, safest medical cannabis available on the market.

Cara is developing lead molecules that selectively modulate peripheral CB receptors without targeting CNS cannabinoid receptors. Peripheral CB receptor modulators will be initially developed as a novel therapeutic approach for neuropathic and inflammatory pain, a condition currently without consistently effective therapies. Its lead product candidate includes I. CR, which is in Phase III clinical trials for the treatment of acute postoperative pain in adult patients, as well as completed Phase II clinical trials for the treatment of uremic pruritus disease, an intractable systemic itching condition which occurs among people with Chronic Kidney Disease.

The company is also developing Oral CR, which is in Phase IIa clinical trials for the treatment of moderate-to-severe acute and chronic pain. It has licensing agreements with Chong Kun Dang Pharmaceutical Corporation to develop, manufacture, and commercialize products containing CR in South Korea; and Maruishi Pharmaceutical Co.

GW Pharmaceuticals plc is a biopharmaceutical company that, together with its subsidiaries, engages in discovering, developing, and commercializing cannabinoid prescription medicines. It operates through three segments: Commercial, Sativex Research and Development, and Pipeline Research and Development.

The company primarily offers Sativex, an oromucosal spray for the treatment of spasticity due to multiple sclerosis. It also focuses on the Phase III clinical development program of Sativex for use in the treatment of cancer pain; and Phase 2 trials in other indications, such as neuropathic pain. It operates in the United Kingdom, Europe, the United States, Canada, and Asia. Their Subsys is a sublingual fentanyl spray for breakthrough cancer pain in opioid-tolerant cancer patients in the United States.

Its lead product candidate is Syndros, an orally administered liquid formulation of dronabinol. Syndros helps patients with anorexia symptoms related to weight loss from AIDS. Also in development, Cannabidiol Oral Solution is a synthetic cannabidiol for childhood catastrophic epilepsy syndromes.

The company is also developing other dronabinol line extensions and sublingual spray product candidates. MassRoots is one of the largest and most active technology platforms for cannabis consumers, businesses and activists with over , registered users. It is proud to be affiliated with the leading organizations in the cannabis industry, including the ArcView Group and National Cannabis Industry Association.

It offers electronic cigarettes and related products through its online store mcig. The company also provides marijuana grower services such as commercial grow room design, warehouse customization, greenhouse grows, personal home grow room units, and general marijuana business consulting.

The Scotts Miracle-Gro Company is most well-known for the manufacturing, marketing, and selling of their extensive line of consumer lawn and garden products worldwide.

But CEO Jim Hagedorn is making big bets in hydroponics as he believes legal marijuana is a billion dollar opportunity and the biggest thing ever to happen to the lawn and gardening industry. The company also has a Scotts LawnService segment that offers residential and commercial lawn care, tree and shrub care, and pest control services through the periodic applications of fertilizer and control products.

Canopy Growth Corporation, through its subsidiaries, produces and sells medical marijuana in Canada. They operate a collection of diverse brands and curated strain variety, supported by over half a million square feet of indoor greenhouse production capacity. The company offers dry cannabis and oil products primarily under the Tweed and Bedrocan brands.

Attention Required! | Cloudflare

It also sells its products online. The company was formerly known as Tweed Marijuana Inc. The company acquired Bedrocan Cannabis Corp. Canopy Growth is the largest producer of medical marijuana in Canada. Vitality Biopharma has developed a new class of cannabinoid prodrugs, known as cannabosides, which upon ingestion can enable the selective delivery of THC and cannabidiol CBD to the gastrointestinal tract.

Site-specific delivery could enable oral drug formulations of cannabinoids to provide therapeutic benefits while reducing or avoiding the systemic delivery of THC into the bloodstream. Currently, high concentrations of psychoactive THC in the brain limit the dose of cannabinoids that can be used elsewhere in the body for treatment of pain and inflammation. Most patients are diagnosed before age 30 and require life-long treatment. A prodrug is a medication or compound that, after administration, is metabolized i.

Prodrugs are typically designed to overcome well-known drawbacks of currently available therapies. Its product candidates include ZYN, which is in Phase I clinical trial for the treatment of refractory epilepsy, Fragile X syndrome, and osteoarthritis; and ZYN that is in preclinical stage for the treatment of fibromyalgia and peripheral neuropathic pain.

The state of the marijuana market is more attractive for investors now than ever before. With the initial hype and volatility out of the way, investors can now begin looking at companies with fair or even undervalued market capitalizations.

With several major catalysts coming up, we expect the companies mentioned on this list to progress and execute on their business plans as the overall industry expands. This industry is here to stay and we have created this Free User guide to help all interested investors get started!

Wednesday, June 21, Marijuana Stocks Welcome to Marijuana Stocks Advertising Content Submission Contact us.

Mexico Passes Law Legalizing Medical Marijuana. Medical Marijuana Could Cost Big Pharma Five Billion in the Next Few Years. The Amazing Effects Of Cannabis On The Brain And Body.

International Consolidated Companies, Inc. INCC Enters Into an Exclusive License Agreement for a CBD. VBIO Advisor to Present Pediatric IBD Case Study.

CARA Reports Continuation of Phase 3 Trial of I. FBEC Announces Summer Event Launch. NORML Pledges to Fight After Trump Cabinet Speaks of Marijuana Crackdown.

Marijuana Protection Policies Are Trying To Be Eliminated By Jeff Sessions. Florida Legislators Reach an Agreement For Medical Marijuana Rules and Regulations. Massachusetts Redesigns Voter-approved Cannabis Legislation With Major Tax Increase. Is Smoking Cannabis the Key to a Happier, Better Life?

Welcome to Marijuana Stocks | Marijuana Stocks

The Key To A Happier Life? Marijuana Now OK For Secret Service? Home Content Focus List. Best Marijuana Stocks to keep focused on, This is our Focus List On this page you will find a list of companies that in our opinion have long term potential.

ACBFF Aurora Cannabis Inc. CARA Cara Therapeutics, Inc. GW Pharmaceuticals plc NASDAQ: GWPH GW Pharmaceuticals plc is a biopharmaceutical company that, together with its subsidiaries, engages in discovering, developing, and commercializing cannabinoid prescription medicines. INSY Insys Therapeutics, Inc.

MSRT MassRoots is one of the largest and most active technology platforms for cannabis consumers, businesses and activists with over , registered users. The Scotts Miracle-Gro Company NYSE: SMG The Scotts Miracle-Gro Company is most well-known for the manufacturing, marketing, and selling of their extensive line of consumer lawn and garden products worldwide. Canopy Growth Corporation CGC. TWMJF Canopy Growth Corporation, through its subsidiaries, produces and sells medical marijuana in Canada.

List of Marijuana Stocks - Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™

VBIO Cannabosides — A New Class of Cannabinoid Pharmaceuticals Vitality Biopharma has developed a new class of cannabinoid prodrugs, known as cannabosides, which upon ingestion can enable the selective delivery of THC and cannabidiol CBD to the gastrointestinal tract.

ZYNE Zynerba Pharmaceuticals, Inc.

Its product candidates include ZYN, which is in Phase I clinical trial for the treatment of refractory epilepsy, Fragile X syndrome, and osteoarthritis; and ZYN that is in preclinical stage for the treatment of fibromyalgia and peripheral neuropathic pain Summary The state of the marijuana market is more attractive for investors now than ever before. We are your 1 source for all things Marijuana Stocks, Subscribe Below! We will NEVER share, sell, barter, etc.

By subscribing you agree we can send you via email our free e-newsletter on marijuana stocks related, articles, news and trade alerts. Further questions please contact privacy marijuanastocks.